Diversity in Life Science Programs
Broadening Participation through Outreach Programs
For greater than a decade Keystone Symposia has engaged in designated activities and programs to broaden participation by scientists from underrepresented backgrounds not only at our research meetings but also within the greater life sciences community. In addition to scholarships to attend our meetings, travel awards for Early Career Scientists from underrepresented backgrounds, The Fellows Program, global travel awards, Peer to Peer sessions at KS meetings and other initiatives, a significant amount of outreach is conducted annually to share information on the opportunities available at Keystone Symposia for scientists from both underrepresented and majority backgrounds. Click here to view our stable of research meetings.
Dr. Laina King, Director, Diversity in Life Science Programs and mentor for the Keystone Symposia Fellows Program, travels to academic institutions, bio-techs, pharmaceutical corporations, scientific societies and others by invitation. Such outreach may take the form of formal slide presentations to an audience of graduate students, Postdoctoral Fellows, administrators and faculty; or more informal talks in a seminar format. Sometimes an institution or organization is interested in collaborating on a particular activity or program or perhaps a researcher or department chair is interested in exposing graduate students and postdocs to the stable of meetings, scholarships and travel awards available to attend our high-power national and international meetings. In all of these cases as well as others, Dr. King is available to provide a presentation or talk on opportunities at Keystone Symposia. Current partnerships with Keystone Symposia include those with Biogen Idec, Novartis and Harvard University.
Laina King, Ph.D. joined Keystone Symposia in 2008, coming from a large regional health sciences center where she was Academic Dean and Professor of Pharmaceutical Sciences. Prior to this appointment she had also held a tenured appointment as Associate Professor of Management at an AACSB School of Business in Colorado. She is currently an FDA Advisory Committee voting member at the CEDR division of the US Food & Drug Administration. She has consulted with organizations such as Jones Intercable and International University, The North Central Association, Middle States Association and the U.S. Department of Defense where she was Japan Consultant. She has served as a Board member on the American Medical Association/Association of American Medical Colleges-Liaison Committee on Medical Education (LCME) which accredits medical schools in the U.S. and Canada. She is currently the P.I. for an NIH MARC T-36 grant. She is a member of the External Review Committee for Brown University's IMSD Program. Dr. King received her B.A., M.A. and Ph.D. from The University of Michigan at Ann Arbor.